Gary Clark: Unfiltered

With permits secured and $15 million in the bank, King Copper is deploying drills in southern Peru to chase a massive copper-gold porphyry system.

The AMA's Category I CPT code approval for Vektor Medical's vMap signals a major shift, turning computational ECGs into commercial reality.

Gary Clark explores the business of executive speaking competitions, analyzing how WILDx VOLTARA monetizes thought leadership and networking in Beverly Hills.

Armed with a $500M war chest and a $1B valuation, CRM challenger Brevo is using situational comedy to aggressively target US incumbents like HubSpot.

As CMS tightens its grip on risk adjustment data, PACE organizations are turning to specialized tech to bridge the gap between clinical care and reimbursement.

As retail investors flood the private markets, ADISA’s inaugural awards highlight the gatekeepers bringing institutional rigor to alternative investments.

As offshore platforms and tech disrupters drain provincial revenues, Canada's crown lotteries are fighting back with a powerful new national alliance.

As chips shrink below 2nm, traditional failure analysis destroys the defects it seeks to find. JEOL’s new HAXIS platform offers a contactless lifeline.

Gary Clark explores how BCS Financial's unique ownership structure and 90% employee satisfaction rate create a competitive moat in the 2026 insurance market.

SINTX Technologies smashed Q3 guidance with a pivot to aerospace ceramics, triggering a warrant call that forces investors to weigh dilution against growth.

Executive compensation firm Pearl Meyer just ranked as a top workplace. Gary Clark explores how they maintained culture during a sudden leadership shift.

ViroMissile's intravenously delivered oncolytic virus, IDOV-2, shows early signs of stable disease in Phase I, hinting at a breakthrough for metastatic cancers.

Former cabinet minister Marci Ien takes the helm at the George Brown Foundation, signaling a strategic shift in how urban colleges fund student survival.

As geopolitical tensions threaten rare earth supplies, corporate giants and private equity are turning to the digital junkyard for domestic autonomy.

To unlock the true potential of AI in drug discovery, Big Pharma must first clean its messy data. Novartis just made a massive move to do exactly that.

As CFOs scrutinize corporate training budgets, Explorance's MTM 10.0 update aims to replace outdated satisfaction scores with hard data on workforce skills.

With generative AI breaking traditional subscription models, Maxio's new Wallets infrastructure targets the accounting nightmare of tokenized consumption.

As climate volatility threatens early-season revenue, Tamarack Resort is deploying automated snowmaking to secure market share and real estate values.

As the token costs of frontier models soar, Ammonix emerges with a neuro-inspired, hybrid AI architecture designed for high-stakes enterprise realities.

A 50-basis-point margin cut on a $1.95 billion debt stack reveals a masterclass in capital structure optimization and post-merger integration.